Similarity Score |
Similarity Level |
Drug ID |
Developmental Stage |
0.8729 |
High Similarity |
NPD4338 |
Clinical (unspecified phase) |
0.8525 |
High Similarity |
NPD7808 |
Phase 3 |
0.8516 |
High Similarity |
NPD7993 |
Clinical (unspecified phase) |
0.847 |
Intermediate Similarity |
NPD7251 |
Discontinued |
0.8449 |
Intermediate Similarity |
NPD8397 |
Clinical (unspecified phase) |
0.8415 |
Intermediate Similarity |
NPD6797 |
Phase 2 |
0.8362 |
Intermediate Similarity |
NPD4868 |
Clinical (unspecified phase) |
0.8361 |
Intermediate Similarity |
NPD7074 |
Phase 3 |
0.8361 |
Intermediate Similarity |
NPD7472 |
Approved |
0.836 |
Intermediate Similarity |
NPD7879 |
Clinical (unspecified phase) |
0.8306 |
Intermediate Similarity |
NPD7054 |
Approved |
0.828 |
Intermediate Similarity |
NPD8312 |
Approved |
0.828 |
Intermediate Similarity |
NPD8313 |
Approved |
0.8251 |
Intermediate Similarity |
NPD3818 |
Discontinued |
0.8242 |
Intermediate Similarity |
NPD6166 |
Phase 2 |
0.8242 |
Intermediate Similarity |
NPD6167 |
Clinical (unspecified phase) |
0.8242 |
Intermediate Similarity |
NPD6168 |
Clinical (unspecified phase) |
0.8108 |
Intermediate Similarity |
NPD7804 |
Clinical (unspecified phase) |
0.8108 |
Intermediate Similarity |
NPD5844 |
Phase 1 |
0.8045 |
Intermediate Similarity |
NPD1465 |
Phase 2 |
0.8011 |
Intermediate Similarity |
NPD4381 |
Clinical (unspecified phase) |
0.801 |
Intermediate Similarity |
NPD8151 |
Discontinued |
0.7935 |
Intermediate Similarity |
NPD6232 |
Discontinued |
0.7912 |
Intermediate Similarity |
NPD7075 |
Discontinued |
0.7903 |
Intermediate Similarity |
NPD7473 |
Discontinued |
0.7901 |
Intermediate Similarity |
NPD3817 |
Phase 2 |
0.7889 |
Intermediate Similarity |
NPD1934 |
Approved |
0.7884 |
Intermediate Similarity |
NPD6559 |
Discontinued |
0.788 |
Intermediate Similarity |
NPD6959 |
Discontinued |
0.7861 |
Intermediate Similarity |
NPD7228 |
Approved |
0.7861 |
Intermediate Similarity |
NPD3751 |
Discontinued |
0.7857 |
Intermediate Similarity |
NPD3882 |
Suspended |
0.785 |
Intermediate Similarity |
NPD7435 |
Discontinued |
0.7845 |
Intermediate Similarity |
NPD2801 |
Approved |
0.7838 |
Intermediate Similarity |
NPD3787 |
Discontinued |
0.7812 |
Intermediate Similarity |
NPD8055 |
Clinical (unspecified phase) |
0.7802 |
Intermediate Similarity |
NPD5402 |
Approved |
0.7796 |
Intermediate Similarity |
NPD7184 |
Clinical (unspecified phase) |
0.7754 |
Intermediate Similarity |
NPD7852 |
Clinical (unspecified phase) |
0.7747 |
Intermediate Similarity |
NPD7819 |
Suspended |
0.7747 |
Intermediate Similarity |
NPD8455 |
Phase 2 |
0.7747 |
Intermediate Similarity |
NPD2393 |
Clinical (unspecified phase) |
0.7747 |
Intermediate Similarity |
NPD7096 |
Clinical (unspecified phase) |
0.7723 |
Intermediate Similarity |
NPD7871 |
Phase 2 |
0.7723 |
Intermediate Similarity |
NPD7870 |
Phase 2 |
0.7707 |
Intermediate Similarity |
NPD7875 |
Clinical (unspecified phase) |
0.7707 |
Intermediate Similarity |
NPD7874 |
Approved |
0.7676 |
Intermediate Similarity |
NPD6234 |
Discontinued |
0.767 |
Intermediate Similarity |
NPD7783 |
Phase 2 |
0.767 |
Intermediate Similarity |
NPD7782 |
Clinical (unspecified phase) |
0.7663 |
Intermediate Similarity |
NPD7768 |
Phase 2 |
0.7634 |
Intermediate Similarity |
NPD5494 |
Approved |
0.7622 |
Intermediate Similarity |
NPD3749 |
Approved |
0.7612 |
Intermediate Similarity |
NPD6776 |
Approved |
0.7612 |
Intermediate Similarity |
NPD6777 |
Approved |
0.7612 |
Intermediate Similarity |
NPD6781 |
Approved |
0.7612 |
Intermediate Similarity |
NPD6779 |
Approved |
0.7612 |
Intermediate Similarity |
NPD6780 |
Approved |
0.7612 |
Intermediate Similarity |
NPD6782 |
Approved |
0.7612 |
Intermediate Similarity |
NPD6778 |
Approved |
0.7594 |
Intermediate Similarity |
NPD7199 |
Phase 2 |
0.7586 |
Intermediate Similarity |
NPD7698 |
Approved |
0.7586 |
Intermediate Similarity |
NPD7697 |
Approved |
0.7586 |
Intermediate Similarity |
NPD7696 |
Phase 3 |
0.7569 |
Intermediate Similarity |
NPD1653 |
Approved |
0.7556 |
Intermediate Similarity |
NPD1512 |
Approved |
0.7524 |
Intermediate Similarity |
NPD7701 |
Phase 2 |
0.7514 |
Intermediate Similarity |
NPD8443 |
Clinical (unspecified phase) |
0.7513 |
Intermediate Similarity |
NPD7240 |
Approved |
0.7513 |
Intermediate Similarity |
NPD7685 |
Pre-registration |
0.7512 |
Intermediate Similarity |
NPD8155 |
Clinical (unspecified phase) |
0.75 |
Intermediate Similarity |
NPD6801 |
Discontinued |
0.75 |
Intermediate Similarity |
NPD37 |
Approved |
0.7486 |
Intermediate Similarity |
NPD4380 |
Phase 2 |
0.7473 |
Intermediate Similarity |
NPD4965 |
Approved |
0.7473 |
Intermediate Similarity |
NPD4967 |
Phase 2 |
0.7473 |
Intermediate Similarity |
NPD4966 |
Approved |
0.7446 |
Intermediate Similarity |
NPD7411 |
Suspended |
0.7444 |
Intermediate Similarity |
NPD1511 |
Approved |
0.7444 |
Intermediate Similarity |
NPD6799 |
Approved |
0.7426 |
Intermediate Similarity |
NPD7699 |
Phase 2 |
0.7426 |
Intermediate Similarity |
NPD7700 |
Phase 2 |
0.7418 |
Intermediate Similarity |
NPD5403 |
Approved |
0.7418 |
Intermediate Similarity |
NPD6980 |
Clinical (unspecified phase) |
0.7416 |
Intermediate Similarity |
NPD7801 |
Approved |
0.7407 |
Intermediate Similarity |
NPD1247 |
Approved |
0.7394 |
Intermediate Similarity |
NPD919 |
Approved |
0.7391 |
Intermediate Similarity |
NPD6599 |
Discontinued |
0.7379 |
Intermediate Similarity |
NPD8320 |
Phase 1 |
0.7379 |
Intermediate Similarity |
NPD8319 |
Approved |
0.7363 |
Intermediate Similarity |
NPD6535 |
Approved |
0.7363 |
Intermediate Similarity |
NPD6534 |
Approved |
0.7333 |
Intermediate Similarity |
NPD6190 |
Approved |
0.7323 |
Intermediate Similarity |
NPD8150 |
Discontinued |
0.7323 |
Intermediate Similarity |
NPD8434 |
Phase 2 |
0.7308 |
Intermediate Similarity |
NPD5401 |
Approved |
0.7282 |
Intermediate Similarity |
NPD6823 |
Phase 2 |
0.7263 |
Intermediate Similarity |
NPD1549 |
Phase 2 |
0.724 |
Intermediate Similarity |
NPD3926 |
Phase 2 |
0.7213 |
Intermediate Similarity |
NPD4378 |
Clinical (unspecified phase) |
0.7213 |
Intermediate Similarity |
NPD7422 |
Clinical (unspecified phase) |
0.7207 |
Intermediate Similarity |
NPD1550 |
Clinical (unspecified phase) |
0.7207 |
Intermediate Similarity |
NPD1552 |
Clinical (unspecified phase) |
0.7182 |
Intermediate Similarity |
NPD3750 |
Approved |
0.7167 |
Intermediate Similarity |
NPD970 |
Clinical (unspecified phase) |
0.7163 |
Intermediate Similarity |
NPD7680 |
Approved |
0.7158 |
Intermediate Similarity |
NPD6143 |
Clinical (unspecified phase) |
0.7158 |
Intermediate Similarity |
NPD7390 |
Discontinued |
0.7136 |
Intermediate Similarity |
NPD7237 |
Clinical (unspecified phase) |
0.7123 |
Intermediate Similarity |
NPD5619 |
Clinical (unspecified phase) |
0.7122 |
Intermediate Similarity |
NPD8090 |
Clinical (unspecified phase) |
0.712 |
Intermediate Similarity |
NPD7410 |
Clinical (unspecified phase) |
0.712 |
Intermediate Similarity |
NPD2533 |
Approved |
0.712 |
Intermediate Similarity |
NPD2532 |
Approved |
0.712 |
Intermediate Similarity |
NPD2534 |
Approved |
0.7059 |
Intermediate Similarity |
NPD7458 |
Discontinued |
0.7056 |
Intermediate Similarity |
NPD1551 |
Phase 2 |
0.7022 |
Intermediate Similarity |
NPD230 |
Phase 1 |
0.7017 |
Intermediate Similarity |
NPD7266 |
Discontinued |
0.7 |
Intermediate Similarity |
NPD1510 |
Phase 2 |
0.6976 |
Remote Similarity |
NPD6214 |
Clinical (unspecified phase) |
0.6976 |
Remote Similarity |
NPD6213 |
Phase 3 |
0.6976 |
Remote Similarity |
NPD6212 |
Phase 3 |
0.6968 |
Remote Similarity |
NPD5808 |
Clinical (unspecified phase) |
0.6968 |
Remote Similarity |
NPD3226 |
Approved |
0.6961 |
Remote Similarity |
NPD2796 |
Approved |
0.6961 |
Remote Similarity |
NPD2935 |
Discontinued |
0.6955 |
Remote Similarity |
NPD7907 |
Approved |
0.6938 |
Remote Similarity |
NPD7501 |
Clinical (unspecified phase) |
0.6935 |
Remote Similarity |
NPD7004 |
Clinical (unspecified phase) |
0.6934 |
Remote Similarity |
NPD7211 |
Clinical (unspecified phase) |
0.6927 |
Remote Similarity |
NPD1933 |
Approved |
0.6906 |
Remote Similarity |
NPD3748 |
Approved |
0.6906 |
Remote Similarity |
NPD651 |
Clinical (unspecified phase) |
0.6902 |
Remote Similarity |
NPD4628 |
Phase 3 |
0.6881 |
Remote Similarity |
NPD7090 |
Clinical (unspecified phase) |
0.6872 |
Remote Similarity |
NPD8127 |
Discontinued |
0.6872 |
Remote Similarity |
NPD1612 |
Clinical (unspecified phase) |
0.6872 |
Remote Similarity |
NPD1613 |
Approved |
0.6872 |
Remote Similarity |
NPD943 |
Approved |
0.6868 |
Remote Similarity |
NPD5406 |
Approved |
0.6868 |
Remote Similarity |
NPD5404 |
Approved |
0.6868 |
Remote Similarity |
NPD5408 |
Approved |
0.6868 |
Remote Similarity |
NPD5405 |
Approved |
0.6862 |
Remote Similarity |
NPD920 |
Approved |
0.6848 |
Remote Similarity |
NPD6674 |
Discontinued |
0.6848 |
Remote Similarity |
NPD7421 |
Clinical (unspecified phase) |
0.6845 |
Remote Similarity |
NPD642 |
Clinical (unspecified phase) |
0.6837 |
Remote Similarity |
NPD7229 |
Phase 3 |
0.6833 |
Remote Similarity |
NPD447 |
Suspended |
0.6829 |
Remote Similarity |
NPD4287 |
Approved |
0.6822 |
Remote Similarity |
NPD7584 |
Approved |
0.6816 |
Remote Similarity |
NPD6233 |
Phase 2 |
0.6811 |
Remote Similarity |
NPD1878 |
Clinical (unspecified phase) |
0.68 |
Remote Similarity |
NPD8058 |
Clinical (unspecified phase) |
0.68 |
Remote Similarity |
NPD8059 |
Phase 3 |
0.6782 |
Remote Similarity |
NPD7549 |
Discontinued |
0.678 |
Remote Similarity |
NPD1530 |
Clinical (unspecified phase) |
0.6778 |
Remote Similarity |
NPD1240 |
Approved |
0.676 |
Remote Similarity |
NPD6859 |
Clinical (unspecified phase) |
0.676 |
Remote Similarity |
NPD6798 |
Discontinued |
0.6758 |
Remote Similarity |
NPD7930 |
Approved |
0.6751 |
Remote Similarity |
NPD5711 |
Approved |
0.6751 |
Remote Similarity |
NPD5710 |
Approved |
0.6742 |
Remote Similarity |
NPD1529 |
Clinical (unspecified phase) |
0.6739 |
Remote Similarity |
NPD2346 |
Discontinued |
0.6738 |
Remote Similarity |
NPD643 |
Clinical (unspecified phase) |
0.672 |
Remote Similarity |
NPD7003 |
Approved |
0.672 |
Remote Similarity |
NPD8166 |
Discontinued |
0.672 |
Remote Similarity |
NPD6398 |
Clinical (unspecified phase) |
0.6714 |
Remote Similarity |
NPD5006 |
Approved |
0.6714 |
Remote Similarity |
NPD5005 |
Approved |
0.6713 |
Remote Similarity |
NPD7585 |
Approved |
0.6712 |
Remote Similarity |
NPD4111 |
Phase 1 |
0.6712 |
Remote Similarity |
NPD4665 |
Approved |
0.6703 |
Remote Similarity |
NPD1607 |
Approved |
0.6701 |
Remote Similarity |
NPD5353 |
Approved |
0.67 |
Remote Similarity |
NPD7177 |
Discontinued |
0.6683 |
Remote Similarity |
NPD5953 |
Discontinued |
0.6683 |
Remote Similarity |
NPD7784 |
Clinical (unspecified phase) |
0.6667 |
Remote Similarity |
NPD7583 |
Approved |
0.6667 |
Remote Similarity |
NPD7286 |
Phase 2 |
0.6648 |
Remote Similarity |
NPD6355 |
Discontinued |
0.6638 |
Remote Similarity |
NPD8067 |
Phase 3 |
0.6633 |
Remote Similarity |
NPD5242 |
Approved |
0.663 |
Remote Similarity |
NPD1509 |
Clinical (unspecified phase) |
0.6622 |
Remote Similarity |
NPD8404 |
Phase 2 |
0.6611 |
Remote Similarity |
NPD3027 |
Phase 3 |
0.6604 |
Remote Similarity |
NPD4420 |
Approved |
0.6599 |
Remote Similarity |
NPD5537 |
Clinical (unspecified phase) |
0.6595 |
Remote Similarity |
NPD6100 |
Approved |
0.6595 |
Remote Similarity |
NPD6099 |
Approved |
0.6593 |
Remote Similarity |
NPD4060 |
Phase 1 |
0.6592 |
Remote Similarity |
NPD9494 |
Approved |
0.6578 |
Remote Similarity |
NPD1243 |
Approved |
0.6578 |
Remote Similarity |
NPD2800 |
Approved |
0.6576 |
Remote Similarity |
NPD7097 |
Phase 1 |
0.6575 |
Remote Similarity |
NPD3764 |
Approved |
0.6573 |
Remote Similarity |
NPD8285 |
Discontinued |
0.6559
|
Remote Similarity |
NPD2344 |
Approved |